Weight Loss & Obesity Management Market Sales & Size to 2034

Weight Loss and Obesity Management Market Overview from 2024 to 2034

The weight loss and obesity management market is projected to rise at a CAGR of 12.8% during the projected period. The market value is projected to increase from US$ 14,511 million in 2024 to US$ 48,396 million by 2034.

Attributes	Details
Weight Loss and Obesity Management Market Size, 2024	US$ 14,511 million
Projected Market Size, 2034	US$ 48,396 million
Value-based CAGR (2024 to 2034)	12.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Weight Loss and Obesity Management Market Size, Analysis, and Insights

The weight loss and obesity management market has been experiencing a surge in demand and the trend is expected to continue in the foreseeable future.
The increasing prevalence of obesity and related health conditions, such as diabetes, heart disease, and hypertension, has fueled the demand for weight loss and obesity management solutions.
As people become more educated about the link between obesity and chronic diseases, they are increasingly seeking out weight loss solutions as a way to improve their overall health and reduce their risk of developing serious health issues.
Changing lifestyle patterns have played a role in driving demand for weight loss and obesity management solutions. As people lead increasingly busy and sedentary lives, they are more likely to experience weight gain and related health issues.

Key Opportunities for Weight Loss and Obesity Management Market Players

The market is a rapidly growing sector, driven by increasing awareness about the risks associated with obesity and the desire for a healthier lifestyle.

The rise of personalized weight loss and obesity management programs is expected to create significant opportunities in the industry.
With the advent of technology, it is now possible to track individual health metrics and create customized programs based on these metrics. Individuals receive tailored recommendations that are specific to their unique needs, increasing the chances of successful weight loss and management.
The growing trend toward non-surgical and minimally invasive procedures for weight loss and obesity management is expected to propel growth in the market.
The rise in the global healthcare industry is also driving the weight loss and obesity management market forward.
Healthcare providers are increasingly recognizing the importance of weight loss and obesity management in preventing chronic diseases such as diabetes and heart disease. Therefore, there is a growing demand for weight loss and obesity management products and services in the healthcare industry.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Weight Loss and Obesity Management Market

The weight loss and obesity management market is experiencing significant growth. However, there are several market challenges that companies in the industry need to address to remain competitive and succeed.

The saturation of the market with weight loss products and services is expected to hamper growth in the coming years.
Consumers have a wide range of options to choose from, including diet plans, supplements, fitness programs, and surgery. With so many choices available, it can be difficult for companies to differentiate themselves and attract customers.
The high cost of several weight loss products and services acts as a restraint. The market is dominated by premium brands that charge premium prices, making it difficult for lower-priced alternatives to gain traction. Additionally, insurance coverage for weight loss treatments is often limited, which can make it hard for consumers to afford the care they need.
Regulatory challenges are also a concern in the weight loss and obesity management market. Many weight loss products and treatments are considered medical devices by regulatory authorities, which means they must undergo rigorous testing and approval processes before they can be sold to consumers.

Category-wise Insights

The Drugs Segment Dominates the Market by Products

Attributes	Details
Top Product	Drugs
Market Share in 2024	48.60%

The increasing demand for effective and efficient weight loss solutions is fueling product sales.
The growing prevalence of obesity and related diseases, such as diabetes, cardiovascular diseases, and cancer, is driving the demand for weight loss drugs.
The pharmaceutical industry is investing heavily in research and development activities to develop innovative weight loss drugs with minimal side effects, which is further stimulating the growth of this segment.

The Institution Sales Segment Leads the Market by Distribution Channel

Attributes	Details
Top Distribution Channel	Institution Sales
Market Share in 2024	75.70%

The increasing prevalence of obesity and related disorders drives institutional sales.
The rising awareness about the health risks associated with obesity and the growing demand for personalized weight loss solutions are also contributing to the growth of the institution's sales segment.
Institutions such as hospitals, clinics, and wellness centers offer a wide range of weight loss solutions, including medical therapies, weight loss surgeries, and lifestyle management programs, which are tailored to the individual needs of the patients.

Country-wise insights

Countries	CAGR (2024 to 2034)
China	5.90%
United Kingdom	4.00%
India	6.20%

Rise of eCommerce Platforms and Online Health and Wellness Portals in India

The rise in disposable income of the middle-class population has led to an increase in spending on health and wellness products in India. People are becoming more conscious of their health and are willing to invest in products and services that can help them achieve their fitness goals.
The growing prevalence of obesity in India has led to increased awareness about the importance of weight management.
The rise of eCommerce platforms and online health and wellness portals has made it easier for consumers to access a wide range of weight loss and obesity management products.
The availability of affordable and effective weight loss and obesity management solutions has also played a significant role in driving market growth in India. There are several products and services available in the market that are tailored to the specific needs of Indian consumers. These include Ayurvedic remedies, low-calorie meal replacements, and fitness programs that cater to different age groups and fitness levels.

Rise in Disposable Income and the Growing Middle Class in China

The rise in disposable income and the growing middle class in China have led to an increased focus on health and wellness. As people become more aware of the negative health impacts of obesity and being overweight, they are seeking out products and services that can help them lose weight and maintain a healthy lifestyle.
The prevalence of obesity in China has been steadily increasing over the past few decades.
The Chinese government has launched several initiatives to combat obesity and promote healthy lifestyles. The initiatives include the implementation of a national fitness program and the promotion of healthy eating habits. As a result, there has been an increased awareness of the importance of weight loss and healthy living among the Chinese population.

Increasing Government Initiatives Addressing the Obesity Epidemic in the United Kingdom

The increasing awareness and concern around the negative health impacts of being overweight or obese in the United Kingdom is driving growth in the market. With the prevalence of obesity and associated health problems such as diabetes, heart disease, and stroke, many individuals are seeking ways to manage their weight and improve their overall health.
The United Kingdom government has been taking steps to address the obesity epidemic, including launching campaigns to promote healthy eating and physical activity, implementing sugar taxes, and investing in weight management programs.
The government initiatives have helped to raise awareness and encourage individuals to take action to manage their weight, which is expected to drive market growth in the region.

Competitive Landscape

The market is highly competitive, with numerous players operating in the industry. Companies offer a range of products and services, including weight loss programs, meal replacements, supplements, and fitness equipment. The market is also characterized by the emergence of several start-ups and niche players who are offering innovative solutions to address the growing demand for weight loss and obesity management products and services.

Recent Developments

In 2021, Phase IIIa study concluded that semaglutide, a weight-loss medication developed by Novo Nordisk, has the potential to improve the physical function and overall well-being of individuals who are obese.
In 2023, a strategic partnership has been announced between PRISTYN CARE, a healthcare service provider, and Allurion, a company that specializes in developing medical devices for weight loss. Through this partnership, the two companies aim to offer a comprehensive platform for obesity care and weight-loss solutions.
In 2022, Amgen Inc. recently shared Phase 1 findings about AMG 133, a new bispecific molecule designed as a glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist. The study aimed to assess the impact of this first-in-human molecule on individuals with obesity but without diabetes, with a focus on evaluating its safety, tolerability, pharmacokinetic, and pharmacodynamics effects.

Key Market Players

Atkins Nutritionals, Inc.
Ethicon US, LLC
Herbalife Ltd.
Nutrisystem, Inc.
Weight Watchers International, Inc.
Jenny Craig, Inc.
Apollo Endosurgery, Inc.
Brunswick Corporation
Covidien plc

Key Coverage in the Weight Loss and Obesity Management Market Report

Obesity Prevention Strategies Analysis
Weight Loss and Obesity Management Market Assessment
Obesity Treatment Industry Outlook
Obesity Management Pricing Analysis
Demand for Bariatric Surgery Devices Overlook

Key Market Segmentation

By Product Type:

Devices
- Liposuction Devices
- Laser-assisted Liposuction Devices
- Radio Frequency-assisted Liposuction Devices
- Ultrasound-assisted Liposuction Devices
- Bariatric Stapling Devices
- Gastric Bands
- Gastric Balloon Systems
- Gastric Emptying Systems
- Gastric Electrical Stimulation Systems
Drugs
- GLP-1 Receptor Agonists
- Lipase Inhibitors
- Serotonin Receptor Agonists
- Combination Drugs
- Others

By Distribution Channel:

Institutional Sales
- Hospitals
- Weight Loss Clinics
- Ambulatory Surgery Centers
Retail Sales
- Retail Pharmacies
- Drug Stores
- Online Sales

By Region:

North America
Latin America
East Asia
South Asia
Europe
Oceania
MEA

Frequently Asked Questions

How Big is the Weight Loss and Obesity Management Market in 2024?

The weight loss and obesity management market is estimated to be valued at around US$ 14,511 million in 2024.

What is China’s Market Outlook?

The market in China is expected to progress at a CAGR of 5.90% over the forecast period.

Which Product Segment Contributes More to the Weight Loss and Obesity Management Market?

Within the products, the drugs segment is expected to register a 48.60% market share in 2024.

What is the India's Market Outlook?

The market in India is projected to expand at a 6.20% CAGR from 2024 to 2034.

What is the Projected Value of the Market by 2034?

The market is set to reach a valuation of around US$ 48,396 million by 2034.

What Was the Historical CAGR for the Market?

The demand for weight loss and obesity management increased at a 23.9% CAGR from 2019 to 2023.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034

5.3.1. Devices

5.3.1.1. Liposuction Devices

5.3.1.2. Laser-assisted Liposuction Devices

5.3.1.3. Radio Frequency-assisted Liposuction Devices

5.3.1.4. Ultrasound-assisted Liposuction Devices

5.3.1.5. Bariatric Stapling Devices

5.3.1.6. Gastric Bands

5.3.1.7. Gastric Balloon Systems

5.3.1.8. Gastric Emptying Systems

5.3.1.9. Gastric Electrical Stimulation Systems

5.3.2. Drugs

5.3.2.1. GLP-1 Receptor Agonists

5.3.2.2. Lipase Inhibitors

5.3.2.3. Serotonin Receptor Agonists

5.3.2.4. Combination Drugs

5.3.2.5. Others

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034

6.3.1. Institutional Sales

6.3.1.1. Hospitals

6.3.1.2. Weight Loss Clinics

6.3.1.3. Ambulatory Surgery Centres

6.3.2. Retail Sales

6.3.2.1. Retail Pharmacies

6.3.2.2. Drug Stores

6.3.2.3. Online Sales

6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

8.2.1. By Country

8.2.1.1. USA

8.2.1.2. Canada

8.2.2. By Product Type

8.2.3. By Distribution Channel

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Product Type

8.3.3. By Distribution Channel

8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Product Type

9.2.3. By Distribution Channel

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Distribution Channel

9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. UK

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Product Type

10.2.3. By Distribution Channel

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Distribution Channel

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Product Type

11.2.3. By Distribution Channel

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Distribution Channel

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Product Type

12.2.3. By Distribution Channel

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Distribution Channel

12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Product Type

13.2.3. By Distribution Channel

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Distribution Channel

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Product Type

14.2.3. By Distribution Channel

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Distribution Channel

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. USA

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2023

15.1.2.1. By Product Type

15.1.2.2. By Distribution Channel

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2023

15.2.2.1. By Product Type

15.2.2.2. By Distribution Channel

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2023

15.3.2.1. By Product Type

15.3.2.2. By Distribution Channel

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2023

15.4.2.1. By Product Type

15.4.2.2. By Distribution Channel

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2023

15.5.2.1. By Product Type

15.5.2.2. By Distribution Channel

15.6. UK

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2023

15.6.2.1. By Product Type

15.6.2.2. By Distribution Channel

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2023

15.7.2.1. By Product Type

15.7.2.2. By Distribution Channel

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2023

15.8.2.1. By Product Type

15.8.2.2. By Distribution Channel

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2023

15.9.2.1. By Product Type

15.9.2.2. By Distribution Channel

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2023

15.10.2.1. By Product Type

15.10.2.2. By Distribution Channel

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2023

15.11.2.1. By Product Type

15.11.2.2. By Distribution Channel

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2023

15.12.2.1. By Product Type

15.12.2.2. By Distribution Channel

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2023

15.13.2.1. By Product Type

15.13.2.2. By Distribution Channel

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2023

15.14.2.1. By Product Type

15.14.2.2. By Distribution Channel

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2023

15.15.2.1. By Product Type

15.15.2.2. By Distribution Channel

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2023

15.16.2.1. By Product Type

15.16.2.2. By Distribution Channel

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2023

15.17.2.1. By Product Type

15.17.2.2. By Distribution Channel

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2023

15.18.2.1. By Product Type

15.18.2.2. By Distribution Channel

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2023

15.19.2.1. By Product Type

15.19.2.2. By Distribution Channel

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2023

15.20.2.1. By Product Type

15.20.2.2. By Distribution Channel

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2023

15.21.2.1. By Product Type

15.21.2.2. By Distribution Channel

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2023

15.22.2.1. By Product Type

15.22.2.2. By Distribution Channel

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2023

15.23.2.1. By Product Type

15.23.2.2. By Distribution Channel

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Product Type

16.3.3. By Distribution Channel

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. GlaxoSmithKline plc.

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. Allergan Plc

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. Johnson & Johnson Services, Inc.

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. Vivus Inc.

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. Eisai Co., Ltd.

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. ReShape Lifesciences, Inc.

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. Aspire Bariatrics

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. Allurion Technologies Inc.

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. Cheplapharm Arzneimittel GmbH

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

17.1.10. Beijing Noble Laser Technology Co., Ltd.

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.10.5.2. Product Strategy

17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Weight Loss and Obesity Management Market

Weight Loss and Obesity Management Market Analysis by Internation Sales and Retail Sales Distribution Channels for 2024 to 2034